Fig. 6

Box plot for estimated 14 tissue proportions from WGBS data of ALS patients and control subjects using Type I and Type II methylation markers. ALS patients exhibited a significantly lower proportion of cfDNA from T-cells and B-cells compared to controls, while showed an increased proportion of cfDNA originating from the liver